Valeo Pharma: Funding, Investors & Team (Sep 2026)
Valeo Pharma is devoted to providing healthcare professionals and patients with the highest quality specialty products and healthcare solutions. Valeo Pharma concentrates on the commercialization of specialized innovative products addressing the needs of patients suffering from complicated or rare diseases.
Valeo Pharma has raised $45.0M across 2 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Sep 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Valeo Pharma Company Profile and Key Stats
Latest funding round on record: Sep 2023.
Valeo Pharma Funding Rounds
Valeo Pharma raised $40.0M in a Post-IPO Debt announced in Aug 2022.
1.1 years later, an undisclosed round of $5.0M was announced in Sep 2023.
Valeo Pharma Founders and Leadership Team
Contact details for the Valeo Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Valeo Pharma Funding Compared to Other Biotechnology Startups
Valeo Pharma's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Valeo Pharma in Biotechnology and Kirkland
Companies Similar to Valeo Pharma
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Valeo Pharma Funding FAQs
What does Valeo Pharma do?
Valeo Pharma is devoted to providing healthcare professionals and patients with the highest quality specialty products and healthcare solutions. Valeo Pharma concentrates on the commercialization of specialized innovative products addressing the needs of patients suffering from complicated or rare diseases.
How much funding has Valeo Pharma raised?
Valeo Pharma has raised $45.0M across 2 rounds on record. The most recent is an undisclosed round of $5.0M announced in Sep 2023.
When did Valeo Pharma last raise funding?
Valeo Pharma's most recent funding round on record is an undisclosed round of $5.0M, announced in Sep 2023.
Who is the CEO of Valeo Pharma?
Steve Saviuk is listed as CEO at Valeo Pharma.
Where is Valeo Pharma headquartered?
Valeo Pharma is based in Kirkland, Quebec, Canada.
How many employees does Valeo Pharma have?
Valeo Pharma is in the 101-250 employee band.
How does Valeo Pharma's funding compare to other Biotechnology startups?
Valeo Pharma's latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Valeo Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Valeo Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.